Home / Inspections / 1201859

FDA Inspection 1201859 — Prospect-Crozer, LLC dba Crozer Health IRB

Prospect-Crozer, LLC dba Crozer Health IRB — FEI 2521121

The FDA completed an inspection of Prospect-Crozer, LLC dba Crozer Health IRB on February 13, 2023 in Chester, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 13, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Chester, PA (United States)

Additional Details

IRB

Facility

Other inspections at this facility

  • 1003357 (NAI Wed Feb 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 914512 (NAI Thu Feb 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 809831 (NAI Fri Dec 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 701150 (NAI Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 621432 (VAI Wed Oct 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources